Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9DFL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,385
Award facts
- Contract value 100% obligated
- $24,384.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $24,384.83 for Biktarvy 50-200-25 mg tablets (30-count units) on January 14, 2026, with an ultimate completion date of January 15, 2026. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), serves as a critical vendor in the federal medical procurement supply chain. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill competitive procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This delivery order for Biktarvy—an antiretroviral medication—exemplifies the company's ongoing role in supplying essential pharmaceutical commodities to support military and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F9DFL?
SPE2DR26F9DFL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F9DFL worth?
The government has obligated $24,385 on SPE2DR26F9DFL.
Is contract SPE2DR26F9DFL an order under another contract?
Yes. SPE2DR26F9DFL is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DFL competed?
The extent of competition for SPE2DR26F9DFL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award